Jon Coleman - 22 May 2025 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
EVP, Chief Commercial Officer
Signature
/s/ Jereme M. Sylvain, as Attorney-in-Fact for Jon Coleman
Issuer symbol
DXCM
Transactions as of
22 May 2025
Net transactions value
$0
Form type
4
Filing time
27 May 2025, 16:12:24 UTC
Previous filing
31 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Coleman Jon EVP, Chief Commercial Officer 6430 SEQUENCE DRIVE, SAN DIEGO /s/ Jereme M. Sylvain, as Attorney-in-Fact for Jon Coleman 27 May 2025 0001442689

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Award $0 +68,738 $0.000000 68,738 22 May 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in four equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock.